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Re´sultat.– La moyenne d’âge des 34 patients inclus était de 56,2  9,2 ans et
58,8 % des patients étaient de sexe féminin. Tous les patients inclus étaient
diabétiques et hypertendus sous traitement. L’IMC moyen était de 30,2  4,8 et
le tour de taille moyen de 107,8  9,3 cm. Le score USP total était de 8,3  6.
29 patients avaient un syndrome clinique d’hyperactivité vésicale et 13 patients
avaient une incontinence urinaire d’effort. Le sous-score USP hyperactivité
vésicale était positivement corrélé à l’âge, la valeur de tour de taille, à l’IMC et à
la glycémie postprandiale. Les autres paramètres du SM n’étaient pas corrélés
aux symptômes urinaires. Le score USP total et sous-score hyperactivité
vésicale USP étaient plus altérés chez les patients avec atteinte du système
nerveux autonome mais sans différence significative.
Discussion.– Les symptômes urinaires les plus fréquemment rencontré au cours
du SM étaient l’hyperactivité vésicale et l’incontinence urinaire à l’effort. Les
paramètres du SM qui influenc¸aient le score USP étaient l’obésité abdominale et
l’hyperglycémie. L’hypothèse d’un lien entre SM et hyperactivité vésicale chez
les patients diabétiques avec un SM est donc plausible.
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For spinal cord injury patients with chronic bladder retention/paraplegia and
high pressure/acontractile detrusor overactivity, a combination first line therapy
is often proposed associating an anticholinergic agent (oxybutynin) with
bladder self-catheterization.
We present the case of a 35-year-old patient with paraplegia since May 2007 due
to a traumatic l1 crush fracture leading to posterior displacement of the posterior
wall and the clinical features of equina cauda symptoms. The patient also had a
history of addiction to multiple toxic substances (alcohol, cannabis, rivotril,
artane. . .). The first urodynamic evaluation found an overactive bladder with
dangerously high pressures (> 40 cm H2O). Treatment with Ditropan
#
(oxybutynin) three pills per day was introduced, together with self-
catheterization.
In 2011, it is noted that the patient solicited the medical team four times in order
to renew his ‘‘lost’’ prescriptions. Contact with the pharmacist revealed a
weekly supply of the pill initially prescribed for one month. The patient
eventually admitted misusing the treatment. In his words ‘‘One pill doesn’t do
anything, you really feel the difference with 6! It’s like Artane.’’ He reported a
floating sensation, an over surge in strength, with a decrease in spasticity and a
few palpitations.
Discussion.– Since the 1970s, Artane# (trihexyphenidyl) has been the leading
drug addiction in Reunion Island. The intended effect is euphoria, psychic
stimulation with a sense of omnipotence and a stimulating effect close to
amphetamines, crack and ecstasy. It is often absorbed with a caffeinated drink:
coffee, soda, energy drinks like ‘‘Red Bull’’ in order to prolong the
psychostimulant effect and limit the amnesia. There is an important black
market for Artane1 in Reunion Island where it is sold for 5–10 s the tablet. In
France, misuse of Artane is a specificity of Reunion Island. Worldwide, it is
hugely consumed in Brazil, the North African countries and the Middle East. To
our knowledge misuse of Ditropan# (oxybutynin) has not yet described so far in
the medical literature.
Further reading
Mete D Bodereau A, Wind P-Nay, Hurbin E. The misuse of trihexyphenidyl.
Alcoholism and Addiction 2008;30(2):129–35.
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Aims/Purpose.– Appreciate the time of clinical and urodynamic anticholi-
nergics efficacy (Oxybutynin, Trospium) used in detrusor neurogenic
overactivity.
Material and methods.– Our study includes ten neurologics patients
hospitalized in our center and followed prospectively in the first half of
2012. All of them are under intermittent self-catheterization (ISC) and all have
incontinence urinary by neurogenic detrusor overactivity.
They have a clinical and urodynamic assessment before anticholinergic
treatment. The clinical assessment (functional bladder capacity, voiding diary,
leak frequency) as urodynamic (Maximal bladder capacity, compliance and
detrusor contraction amplitude) are made between day 3 and day 7.
Results.–After 5 day of treatment, antimuscarinics drugs have a dual efficacy:
– clinic: 60% of continents patients without any leak;
– urodynamic: maximal bladder capacity (MBC) > 400 mL and detrusor
contraction amplitude (DCA) < 20 cm H2O in 50% of patients.
Discussion/conclusion.– Anticholinergics have a clinical and urodynamic
efficacy in 30% of spinal cord injured patients and still remain the first line
treatment of neurogenic overactive bladder. Their time of efficacy is not
specified in the literature.
Our study reveals a short time of efficacy allowing the treatment adaptation on
average of 5 days.
Further reading
Andersson Karl. Antimuscarinic for treatment of overactive bladder. Lancet
Neurol 2004;3(1):46.
Andersson KE, Appel R, Cardozo et al. Pharmacological treatment of urinary
incontinence. 3rd International Consultation on Incontinence. p. 811, 2005.
Madhuvrata P, Singh M, Hasafa Z, Abdel-Fattah M. Anticholinergic drugs for
adult neurogenic detrusor overactivity: a systematic review and meta-analysis.
Eur Urol. 2012. [Epub ahead of print].
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Introduction.– Neurological damage caused by thiamine’s deficiency are most
often related to chronic alcoholic intoxication. Vomiting in pregnancy are rarely
post in question. The association with bladder disorders is exceptional.
Observation.–We report the case of a patient aged 39 years with no significant
medical history. At 9 weeks pregnancy, she presented uncontrollable vomiting
with anorexia and secondary, occurrence of tetraparesis with ataxia, headache,
memory impairment, associated with urinary disorders (retention, dysuria). The
diagnosis of encephalitis of Gayet Wernicke by vitamin B1 deficiency was
made. The patient received supplementation with vitamin B1 associated with a
high protein and high-calorie diet with a good evolution of the general plan.
Intermittent catheterisation were necessary after removal of the catheter
associated with an adequate sensorimotor rehabilitation.
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Troubles ve´sicosphincte´riens (II) / Revue d’E´pide´miologie et de Sante´ Publique 55S (2012) e379–e386e386Discussion.– The possibility of thiamine deficiency should not be raised only
with chronic alcoholic patients, but also in a context of chronic undernutrition
often hidden. The urinary disorders are not always at the forefront of
neurological semiology and can have a central or peripheral appearance.
They must be sought and managed in case of neurological impairment. Their
functional prognosis is often favorable.
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Objective.– Mestinon 60 mg is a parasympathomimetic, cholinesterase
inhibitor, which contains the active pyridostigmine which extends and enhances
the effects of muscarinic and nicotinic acetylcholine. It is usually used in the
treatment of myasthenia and intestinal atony, its use as a treatment for hypo-active
bladder of diabetic subject is recent and has shown excellent results.
The aim of this study is to provide the results of our experience.
Materials and methods.– Twenty-four diabetic patients with underactive bladder
confirmed by urodynamic studies were treated with Mestinon 60 mg dose to one
tablet twice per day, the evaluation was clinical, ultrasound and urodynamics.
Results.– The average patient age was 59 years, the median duration of diabetes
before treatment was 11 years, diabetes type I was interested in 88% of patients.
Treatment with 60 mg Mestinon restored a good clinical improvement with
urination, ultrasound (absence of post-voiding residue) and urodynamics in
96% of cases.
No adverse effects were noted except for one case of diarrhea. During the
median follow-up to 3 years, the results were stable.
Discussion.– Excellent results of Mestinon and lack of side effects, this
treatment needs to be prescribed as first line diabetes underactive bladder.
http://dx.doi.org/10.1016/j.rehab.2012.07.986P049-e
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Introduction.– Lower urinary tract symptoms (LUTS) are under-evaluated in
metabolic syndrome (MS). Many factors in this syndrome are implicated to
develop LUTS. The goals of this study were to analyze the frequency of the
LUTS in patients with MS and to examine the potential role of MS components
in the development of LUTS.
Methods.– We used urinary symptom profile (USP) to evaluate LUTS. The
physical examination included: weight, waist circumference, body mass index
(BMI) and blood pressure looking for orthostatic hypotension. The following
laboratory data were obtained: fasting blood sugar, postprandial glycemia,
glycosylated hemoglobin (HbA1c), HDL cholesterol, LDL cholesterol,
triglycerides and total cholesterol.
Results.– The average age of 34 enrolled patients was 56.2  9.2 years and
58.8% of patients were female. All patients had diabetic and hypertension
therapy. The mean of BMI was 30.2  4.8 and waist circumference
was 107.8  9.3 cm. USP total score was 8.3  6. Twenty-nine patients had
overactive bladder symptom, and 13 patients had urinary incontinence. The
overactive bladder USP score was positively correlated with age, waist
circumference, BMI and postprandial glycemia. The other components of MS
did not correlate with urinary symptoms. Total USP score and sub-score USP
were more alterated in patients with involvement of the automatic nervous
system, but not significantly.
Discussion.– The most frequency urinary symptom in the MS was overactive
bladder and urinary incontinence. The components of MS that influenced the
USP score were abdominal obesity and hyperglycemia. The hypothesis of
link between MS and overactive bladder in diabetic patients with MS is
plausible.
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